Xanthippi Alexi Selected Research

Xanthippi Alexi Research Topics

7	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2006
5	Neoplasms (Cancer) 01/2020 - 05/2007
2	Adenocarcinoma 04/2010 - 07/2009
1	Carcinogenesis 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 04/2013
1	Endocrine Gland Neoplasms (Cancer, Endocrine) 04/2010

3	Estrogens (Estrogen)FDA Link 01/2018 - 07/2009
3	Estrogen ReceptorsIBA 01/2018 - 01/2011
2	Tamoxifen FDA LinkGeneric 01/2020 - 08/2015
2	Fulvestrant (Faslodex)FDA Link 01/2018 - 05/2006
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 04/2013
2	IsoflavonesIBA 05/2012 - 04/2010
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2020
1	Hormones (Hormone)IBA 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	ResveratrolIBA 01/2016
1	Phenobarbital (Luminal)FDA Link 08/2015
1	Messenger RNA (mRNA)IBA 08/2015
1	Serine (L-Serine)FDA Link 08/2015
1	Estrogen Receptor alphaIBA 08/2015
1	Transcription Factors (Transcription Factor)IBA 12/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2013
1	Aromatase InhibitorsIBA 11/2013
1	2- (2,4- dihydroxyphenyl)- 3- formyl- 4- hydroxy- 6- methoxy- 5- (3- methylbuten- 2- yl)benzofuranIBA 04/2013
1	biochanin AIBA 05/2012
1	Phytoestrogens (Phytoestrogen)IBA 05/2007
1	SteroidsIBA 05/2007
1	PhytoalexinsIBA 05/2007
1	benzofuranIBA 05/2007
1	Dihydrotachysterol (AT 10)IBA 05/2006
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2006